Skip to main content
Premium Trial:

Request an Annual Quote

Paul Song

Cynvenio Biosystems has hired Paul Song as its chief medical officer to oversee the firm's translational and clinical research programs. He will be responsible for all clinical utility activities, including trial definition, institutional partner selection, and patient stratification. He also will coordinate global activities with international partners, in particular those in Europe and China. Song is on the faculty at Cedars Sinai Medical Center and is CMO at AT-Gen. He is also a senior adviser at Berg Health.

The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.